Australia markets closed

Genetron Holdings Limited (GTH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8279+0.0099 (+1.21%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8180
Open0.8400
Bid0.0000 x 2900
Ask0.0000 x 1300
Day's range0.8060 - 0.8690
52-week range0.7310 - 14.6000
Volume52,528
Avg. volume308,289
Market cap75.01M
Beta (5Y monthly)0.35
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

    BEIJING, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that the special committee (the “Special Committee”) of the Company’s Board of Directors (the “Board”) has retained Kroll, LLC (operating through its Duff & Phelps Opinions Practice

  • GlobeNewswire

    Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

    BEIJING, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that its Board of Directors (the “Board”) has received a preliminary non-binding proposal letter dated August 21, 2022 (the “Proposal Letter”) from Mr. Sizhen Wang, co-founder, chair

  • GlobeNewswire

    Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day

    BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will be participating in the virtual Goldman Sachs Healthcare Corporate Day. Genetron’s management team, Sizhen Wang, co-founder and Chief Executive Officer and Evan